Approval · Notice of Compliance 3364 · 2003
VIRACEPT: Notice of Compliance 3364
Issued December 30, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3364
- Date
- December 30, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 625mg tablets
- Therapeutic class
- Hiv protease inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIRACEPT | 02248761 | Cancelled Post Market |
Medicinal ingredients
- NELFINAVIR MESYLATE 625 MG per TAB